Rafat Abonour, MD, on What Nurses Should Know About the Expanded Indication for Ide-Cel in Myeloma

Rafat Abonour, MD, of the Indiana University School of Medicine, discusses what nurses should know about the recently expanded indication for idecabtagene vicleucel and the KarMMa-3 trial results that it was based on.

“The progression-free survival endpoint was met… The responses were incredible,” Dr. Abonour said of the KarMMa-3 trial results.

Advertisement

Latest News

Advertisement
Advertisement
Our Contributors

Expert Interviews

Conference Highlights

Fatemeh Youssefi, PhD, RN, OCNConferences | May 2, 2024
Fatemeh Youssefi, PhD, RN, OCN, and Kim Marchand, RN, OCN, discuss the impact of attending ONS Congress.
View More
Colleen McCracken, MSN, RN, CMSRN, CHPN, OCNConferences | May 1, 2024
The team is already counting down to the 50th Annual ONS Congress, which will be held in Denver, Colorado.
Fatemeh Youssefi, PhD, RN, OCNConferences | April 29, 2024
Fatemeh Youssefi, PhD, RN, OCN, speaks with 2 oncology nurses who presented posters at the ONS Congress.
Denise Furtick, MS, BSN, RNConferences | April 27, 2024
Attendees of the ONS Congress can submit a CARE Award nomination at booth #3087.

Network Websites